Alanen H. M., Finne-Soveri H., Noro A. and Leinonen E. (2006). Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. International Journal of Geriatric Psychiatry, 21, 288–295.
Ballard C., Waite J. and Birks J. (2006) Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD003476. DOI: 10. 1002/14651858. CD003476.pub2.
Bianchetti A., Trabucchi M. and Cipriani G. (2003). Aggressive behavior associated with donepezil treatment: a case report. International Journal of Geriatric Psychiatry, 18, 657–658.
Bouman W. P. and Pinner G. (1998). Violent behavior-associated with donepezil. American Journal of Psychiatry, 155, 1626–1627.
Gill S. S. et al. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study. BMJ, 330, 445–450.
Greve M. and O'Connor D. (2005). A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD). International Psychogeriatrics, 17, 195–205.
Hagen B., Esther C. A., Ikuta R., Williams R. J., Le Navenec C. L. and Aho M. (2005). Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation. International Psychogeriatrics, 17, 179–193.
Lyketsos C. G. et al. (2006). Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. American Journal of Geriatric Psychiatry, 14, 561–572.
National Collaborating Centre for Mental Health (2007). Dementia: a NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline no. 42. http://www.guidance.nice.org.uk/cg42 (last accessed 8 January 2008). Royal College of Psychiatrists (2005). Atypical antipsychotics and behavioural and psychiatric symptoms of dementia. http//www.rcpsych.ac.uk/PDF/BPSD.pdf. (last accessed 25 August 2007).
Schneider L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
Snowdon J., Day S. and Baker W. (2005). Why and how antipsychotic drugs are used in 40 Sydney nursing homes. International Journal of Geriatric Psychiatry, 20, 1146–1152.
Soyinka A. and Lawley D. (2007). Antipsychotic prescribing for behavioural and psychological symptoms of dementia. Psychiatric Bulletin, 31, 176–178.
SPSS Inc. (2006). SPSS Base 14.0 User's Guide. New Jersey: Prentice Hall.
Trifirò G., Verhamme K. M. C., Ziere G., Caputi A. P., Stricker B. H.Ch. and Sturkenboom M. C. J. M. (2007). All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538–544.
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Yorston G. and Pinney A. (2000). Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin, 24, 130–132.